LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 131 pages found matching glaxo- Paxil y HPPR
[ IN ENGLISH ] El 27 de septiembre de 2005, la Adminstración de Alimentos y Drogas (FDA) alertó a los profesionales de la salud y a los consumidores respecto de la modificación introducida por GlaxoSmithKline en su aviso de advertencia de Paxil (paroxetina), en el que se incluyó el riesgo de defectos de nacimiento. Los res... - Daniel Troy - Bush Administration's Preemption Gang - Part I
Feb-25-08 Washington, DC: Judging by the line-up of current and former Bush Administration attorneys representing the pharmaceutical industry against private citizens in courts all over the country, no conflict-of-interest regulations apply to attorneys who work for Bush. The self-identified primary author of the preemption language in the new drug labeling rul... - World Experts Demand End to Child Drugging in the US - Part II
Oct-27-07 Washington, DC: Mathy Milling Downing was a featured speaker at the annual conference of the International Center for the Study of Psychiatry and Psychology and told the audience that her anger is directed toward the FDA and drug companies, "for their incompetence and lack of concern for innocent children they have helped to kill, my little girl included."... - Psychotropic Drug Makers Bankroll Prescribing Shrinks Part I
Aug-30-07 Washington, DC: On August 21, 2007, the Associated Press reported that drug companies spend a lot of money on the members of Minnesota advisory panels who help select the drugs which are to be used by patients covered by Medicaid. The news agency's review of financial disclosure records in Minnesota found that a doctor and a pharmacist on the 8-member p... - Avandia and FDA now subject of Congressional Hearing
Jun-6-07 Washington, DC Diabetes drug Avandia is making the news again this week, on two fronts. On June 6, 2007 a Congressional committee will hold a meeting to address the safety of Avandia, and the question of whether federal drug regulators (read the FDA) have paid close enough attention to its potential risks. The hearing before the House Committee on Ove... - Avandia Concerns Known Since 2000
May-24-07 Chapel Hill, NC The diabetes drug Avandia , which has been in the news this week following a report in the New England Journal of Medicine (NEJM) over concerns of a link to heart problems, continues to percolate throughout the prescription drug world - and telling information, lurking beneath the surface almost since the drug fist came onto the market, is... - Uphill Battle - Warning Pharma Customers about Dangers of SSRIs
Sep-29-06 Recent concerns about the adverse effects of selective serotonin reuptake inhibitor antidepressants (SSRIs) have focused on suicide risks. However, a new study published in the September 2006 journal, Public Library of Science (PLoS), reports that in addition to self-harm, the drugs can also cause some patients to become violent and homicidal. Professor... - Industry giants to pay $500,000 settlement in environmental lawsuit.
San Francisco, CA: (May-19-08) The Department of Justice brought charges against GlaxoSmithKline Plc, Motorola Inc., and Siemens Corp., alleging that system failures at the companies' facilities led to the release of trichloroethylene, or TCE, into the public drinking water system in Scottsdale, AZ. The federal complaint stated that the three companies f... - Avandia Canada Heart Attack and Liver Damage.
A new study from the New England Journal of Medicine published May 21, 2007 links the widely prescribed diabetes drug Avandia to an alleged increased risk of heart attack and even death. The Journal reported that dozens of studies together resulted in alleged evidence of a 43 percent higher risk of heart attack. Since Avandia was approved by the FDA i... - GlaxoSmithKline Faces Zofran Birth Defect Lawsuits
Mar-30-16 Pittsburgh, PA: GlaxoSmithKline faces more Zofran lawsuits alleging babies developed birth defects after being exposed to Zofran in the womb. While some women say their children have outgrown the Zofran side effects, others say the effects have lasted well into their child's life, and traumatized their families. With lawsuits consolidated for pretrial... - Mother's Act Promotes Pregnancy as New Cottage Industry
Dec-5-08 Women of childbearing years represent the most lucrative market for the makers of psychiatric drugs. The knowledge that infants were being born with birth defects and suffering a withdrawal syndrome when these drugs were used during pregnancy was hidden for decades. Knowledge of these terrible risks would have caused a major drop in sales to this customer b... - Avandia Maker Tried to Silence Critic, Feds Allege
Nov-19-07 Washington, DC A noted physician who has been warning about the dangerous side effects of Avandia since 1999, and who was the target of alleged intimidation by Avandia manufacturer GlaxoSmithKline (Glaxo) (GSK), was vindicated Thursday by the US Senate Finance Committee. Operating within its jurisdiction over Medicare and Medicaid, the government comm... - Scientists Demand Action on Avandia: New FDA Panels Formed
Jul-8-07 Cleveland, OH: At the recent American Diabetes Association's annual meeting in Chicago, Dr. Steven Nissen, chief of cardiology at the Cleveland Clinic, said early data on links between Avandia and cardiac events were ignored by the drug's maker, Glaxo Smith Klein, including findings presented at the FDA advisory meeting prior to Avandia's approval. "... - High Anxiety over Avandia Report
May-30-07 Washington, DC Even the United States Senate is getting involved in the worried reaction to the report published last Monday claiming the popular diabetes drug Avandia raises the risk and severity of heart attacks. On May 21 the New England Journal of Medicine reported that an analysis of 42 separate studies on the drug concluded that Avandia rais... - FDA's Preemption Gift to Big Pharma
Nov-20-06 Washington, DC: An item sure to end up on the chopping block with the Democrats back in power, is the Bush administration's multi-billion dollar gift to Big Pharma, that bars people who have been injured by drugs approved by the FDA from suing the drug's maker in state courts. Under the FDA's federal preemption position, victims injured by dangerous dru... - Advair Deadly for Asthmatics
Sep-14-06 Reno, NV "My father had been on Advair for approximately four months for his asthma , and told me that the drug had changed his life," says Dave Connors. He didn't realize that it could cause his death. "In Sept of 2002, my father (age 71) had a fatal cardiac episode. He was driving down the street with my mother when they pulled to the side of the... - Glaxo Looking to Advance Rest of OTC Asset Sales As Alli Side Effects Remain
Feb-1-12 London, England GlaxoSmithKline Plc is trying to sell its remaining over-the-counter medicine brands as quickly as possible, due to the ongoing issues with Alli side effects and other medications, according to Bloomberg . The news outlet reported that the company's chief financial officer noted that they are continuing the process of divesting othe... - Pharma "Sales" Representatives Entitled to California Overtime
Jan-26-12 Sacramento, CA The preliminary approval granted to current and former Novartis Pharmaceutical sales representatives to the tune of $99 million likely has Glaxo sales reps and other pharma sales reps optimistic regarding the outcome of their California Overtime lawsuits. On January 25, 2012, Novartis, which is based in New Jersey, agreed to settle th... - Avandia's Fate is Sealed, Says Doctor. "The Drug is Done"
Aug-5-10 Washington, DC While the US Food and Drug Administration (FDA) has yet to decide on the fate of Avandia in the wake of an expert panel's various recommendations and positions at a summit held in July, some in the medical community say that given the Avandia risks —including heart attack, liver failure and bone fractures—the disappearance of... - Glaxo Settles Paxil Side Effects Lawsuits, Average Settlement $1.2 Million
Jul-28-10 Newark, NJ GlaxoSmithKline (Glaxo), the largest drug manufacturer in the UK, is believed to have paid out about $1 billion to settle various Paxil lawsuits since the drug first came onto the market in 1993. Earlier this month it was announced that Glaxo has agreed to pay another $1 billion to settle more than 800 outstanding cases alleging Paxil birth de...